tiprankstipranks
Advertisement
Advertisement

HOTH Stock Latest News

Hoth Therapeutics Rebrands as Rocket One, Shifts to AI
Company AnnouncementsHoth Therapeutics Rebrands as Rocket One, Shifts to AI
1d ago
8K
HOTH
Hoth Therapeutics Launches Rocket One Space Subsidiary Initiative
PremiumCompany Announcements
Hoth Therapeutics Launches Rocket One Space Subsidiary Initiative
16d ago
8K
HOTH
Hoth Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice
PremiumCompany Announcements
Hoth Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice
18d ago
8K
HOTH
Hoth Therapeutics Resumes At-the-Market Equity Offering Program
PremiumCompany Announcements
Hoth Therapeutics Resumes At-the-Market Equity Offering Program
1M ago
8K
HOTH
Hoth Therapeutics reports results from HT-VA study
PremiumThe Fly
Hoth Therapeutics reports results from HT-VA study
1M ago
HOTH
Hoth Therapeutics reports positive HT-VA CRADA data
PremiumThe FlyHoth Therapeutics reports positive HT-VA CRADA data
1M ago
HOTH
Hoth Therapeutics up 52% at $0.78 per share after HT-VA data
Premium
The Fly
Hoth Therapeutics up 52% at $0.78 per share after HT-VA data
1M ago
HOTH
Hoth Therapeutics Completes Registered Direct Offering Financing
Premium
Company Announcements
Hoth Therapeutics Completes Registered Direct Offering Financing
2M ago
8K
HOTH
Hoth Therapeutics announces $2M registered direct offering
PremiumThe Fly
Hoth Therapeutics announces $2M registered direct offering
2M ago
HOTH
Hoth Therapeutics reports results from ongoing HT-001 program
PremiumThe Fly
Hoth Therapeutics reports results from ongoing HT-001 program
2M ago
HOTH
Hoth Therapeutics announces issuance of Chinese patent
PremiumThe Fly
Hoth Therapeutics announces issuance of Chinese patent
2M ago
HOTH
Hoth Therapeutics’ HT-001 shows positive PK, safety and clinical activity
PremiumThe Fly
Hoth Therapeutics’ HT-001 shows positive PK, safety and clinical activity
2M ago
HOTH
Hoth Therapeutics’ HT-VA shows cholesterol level restoration
PremiumThe FlyHoth Therapeutics’ HT-VA shows cholesterol level restoration
2M ago
HOTH
Hoth Therapeutics announces expansion of CLEER-001 Phase 2a clinical trial
Premium
The Fly
Hoth Therapeutics announces expansion of CLEER-001 Phase 2a clinical trial
3M ago
HOTH
Hoth Therapeutics receives U.S. notice of allowance for Exon-skipping therapy
Premium
The Fly
Hoth Therapeutics receives U.S. notice of allowance for Exon-skipping therapy
3M ago
HOTH
Hoth Therapeutics’ HT-VA GDNF shows superior efficacy in obesity
PremiumThe Fly
Hoth Therapeutics’ HT-VA GDNF shows superior efficacy in obesity
3M ago
HOTH
Hoth Therapeutics confirms it holds no cryptocurrency assets
PremiumThe Fly
Hoth Therapeutics confirms it holds no cryptocurrency assets
4M ago
HOTH
Hoth Therapeutics’ HT-001 shows 100% response in EFGR-treated cancer patients
PremiumThe Fly
Hoth Therapeutics’ HT-001 shows 100% response in EFGR-treated cancer patients
4M ago
HOTH
Hoth Therapeutics receives approval for HT-KIT cancer program patent in China
PremiumThe Fly
Hoth Therapeutics receives approval for HT-KIT cancer program patent in China
4M ago
HOTH
Hoth Therapeutics highlights obesity and pipeline progress to regulators
PremiumCompany AnnouncementsHoth Therapeutics highlights obesity and pipeline progress to regulators
4M ago
8K
HOTH
Hoth Therapeutics expands oncology pipeline with dual patent filings
Premium
The Fly
Hoth Therapeutics expands oncology pipeline with dual patent filings
5M ago
HOTH
Hoth Therapeutics accepted into Nvidia Connect Program
Premium
The Fly
Hoth Therapeutics accepted into Nvidia Connect Program
6M ago
HOTH
NVDA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >